Calithera Biosciences Cash from Financing (TTM) Insights

Calithera Biosciences Inc (CALA)

0.02 0.00 (0.00%) USD | OTCM | May 03, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2022	9.655M
September 30, 2022	10.31M
June 30, 2022	10.29M
March 31, 2022	2.268M
December 31, 2021	10.67M
September 30, 2021	10.51M
June 30, 2021	10.51M
March 31, 2021	43.94M
December 31, 2020	42.06M
September 30, 2020	83.58M
June 30, 2020	83.33M
March 31, 2020	105.41M
December 31, 2019	98.91M
September 30, 2019	65.30M
June 30, 2019	71.24M
March 31, 2019	15.63M
December 31, 2018	14.63M

Date	Value
September 30, 2018	7.988M
June 30, 2018	2.519M
March 31, 2018	2.519M
December 31, 2017	122.95M
September 30, 2017	125.74M
June 30, 2017	128.60M
March 31, 2017	128.15M
December 31, 2016	11.82M
September 30, 2016	7.555M
June 30, 2016	4.732M
March 31, 2016	5.081M
December 31, 2015	0.845M
September 30, 2015	72.20M
June 30, 2015	85.00M
March 31, 2015	87.86M
December 31, 2014	87.87M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

2.268M

Minimum

Mar 2022

105.41M

Maximum

Mar 2020

43.87M

Average

42.06M

Median

Dec 2020

Cash from Financing (TTM) Benchmarks